Breaking News

Inceptua, Bendalis Enter Oncology Clinical Supply Pact

Inceptua gains exclusive access to Bendalis’ portfolio of chemotherapy products commonly used in clinical trials

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Inceptua Group, a global pharmaceutical company and service partner, and Bendalis GmbH, a German manufacturer of generic oncology drugs and special therapeutics, have signed of an exclusive clinical trial supply agreement for oncology generics.  Inceptua will serve as the exclusive distributor of Bendalis’ products for use in clinical trials worldwide, offering clinical trial sponsors access to Brexit-safe oncology standard of care medicines produced within the EU.  Through this agreement,...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters